Marielle E Yohe, M.D.

National Cancer Institute (NCI)

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

1 more share only the name and are not shown

Trial papers in ependymoma

PubMed author-name match

Trials

Studies that name Marielle E Yohe, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:47 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT07891286 · Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young Adults
National Cancer Institute (NCI) · not yet recruiting · LGCMN, Large and Giant Congenital Melanocytic Nevi, NF1 · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in ependymoma.